Bone

SPARK™ CLEAR ALIGNERS ANNOUNCES KEY CLINICAL UPDATES & DOCTOR-DRIVEN INNOVATIONS IN RELEASE 14

Retrieved on: 
Tuesday, August 8, 2023

BREA, Calif., Aug. 8, 2023 /PRNewswire/ -- Ormco Corporation announces the highly anticipated Spark Clear Aligners Release 14.  Release 14 continues Spark's philosophy of giving orthodontists control and flexibility. The Spark Aligner System is already an open platform that accepts scans from all major intraoral scanners. Now with Release 14, doctors will have even greater flexibility with the introduction of Spark Approver Web and seamless DEXIS™ IOS integration, along with exciting clinical and workflow updates.   

Key Points: 
  • BREA, Calif., Aug. 8, 2023 /PRNewswire/ -- Ormco Corporation announces the highly anticipated Spark Clear Aligners Release 14.
  • Now with Release 14, doctors will have even greater flexibility with the introduction of Spark Approver Web and seamless DEXIS™ IOS integration, along with exciting clinical and workflow updates.
  • Ormco also recently launched new clinical updates and user experience features, including:
    Spark's Integrated Hooks now include three size choices in retention attachments.
  • For more information on Spark Release 14 and other recent improvements, please visit https://info.ormco.com/spark-r14-release or contact your Sales Representative.

UT Health Science Center San Antonio recognized as Parkinson's Foundation Comprehensive Care Center

Retrieved on: 
Tuesday, August 1, 2023

SAN ANTONIO, Aug. 1, 2023 /PRNewswire-PRWeb/ -- The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been designated a Parkinson's Foundation Comprehensive Care Center, the first of its kind in the state of Texas.

Key Points: 
  • Advanced multidisciplinary care for Parkinson's disease is available at The University of Texas Health Science Center at San Antonio, which this summer was named a Parkinson's Foundation Comprehensive Care Center.
  • SAN ANTONIO, Aug. 1, 2023 /PRNewswire-PRWeb/ -- The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been designated a Parkinson's Foundation Comprehensive Care Center, the first of its kind in the state of Texas.
  • The UT Health San Antonio Movement Disorders Center is also recognized as a Huntington's Disease Center of Excellence and provides comprehensive care for patients with Huntington's disease.
  • The University of Texas Health Science Center at San Antonio (UT Health San Antonio), a primary driver for San Antonio's $44.1 billion health care and biosciences sector, is the largest academic research institution in South Texas with an annual research portfolio of more than $360 million.

Feed Phosphates Market worth $3.2 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, July 31, 2023

CHICAGO, July 31, 2023 /PRNewswire/ -- The Feed Phosphates Market is estimated at USD 2.6 billion in 2023 and is projected to reach USD 3.2 billion by 2028, at a CAGR of 4.0% from 2023 to 2028 according to a report published by MarketsandMarkets™.

Key Points: 
  • CHICAGO, July 31, 2023 /PRNewswire/ -- The Feed Phosphates Market is estimated at USD 2.6 billion in 2023 and is projected to reach USD 3.2 billion by 2028, at a CAGR of 4.0% from 2023 to 2028 according to a report published by MarketsandMarkets™.
  • Feed phosphates contribute to the overall health and performance of animals, including bone development, energy metabolism, and immune function.
  • Livestock and poultry farmers are increasingly aware of the benefits of feed phosphates in enhancing animal well-being, leading to their higher adoption.
  • The feed phosphates market industry has been studied in North America, Europe, Asia Pacific, South America and Rest of the World.

Feed Phosphates Market worth $3.2 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, July 31, 2023

CHICAGO, July 31, 2023 /PRNewswire/ -- The Feed Phosphates Market is estimated at USD 2.6 billion in 2023 and is projected to reach USD 3.2 billion by 2028, at a CAGR of 4.0% from 2023 to 2028 according to a report published by MarketsandMarkets™.

Key Points: 
  • CHICAGO, July 31, 2023 /PRNewswire/ -- The Feed Phosphates Market is estimated at USD 2.6 billion in 2023 and is projected to reach USD 3.2 billion by 2028, at a CAGR of 4.0% from 2023 to 2028 according to a report published by MarketsandMarkets™.
  • Feed phosphates contribute to the overall health and performance of animals, including bone development, energy metabolism, and immune function.
  • Livestock and poultry farmers are increasingly aware of the benefits of feed phosphates in enhancing animal well-being, leading to their higher adoption.
  • The feed phosphates market industry has been studied in North America, Europe, Asia Pacific, South America and Rest of the World.

Rescued Senior Dog Joins Family of 14 Rescue Dogs

Retrieved on: 
Thursday, July 27, 2023

CLIFTON PARK, N.Y., July 27, 2023 /PRNewswire/ -- The Mr. Mo Project, a non-profit organization for senior dogs, and home to 18 rescue dogs, has partnered with YuMOVE, the official dog joint supplement of the American Kennel Club. Their mission is simple - they want to work together to help senior dogs across the U.S. live out their best and most active lives. 

Key Points: 
  • Their mission is simple - they want to work together to help senior dogs across the U.S. live out their best and most active lives.
  • The Mr. Mo Project rescues and advocates for senior and special needs dogs from shelters, helping to find them loving forever homes.
  • Having helped thousands of senior dogs, one dog's remarkable story has gone from good to great in just a few short months.
  • Many senior dogs can have mobility concerns and YuMOVE helps to support these dogs become more active as we find new homes with loving families for them."

Onkos Surgical Announces Expanded Capability in Pediatric Musculoskeletal Oncology and Unveils New Manufacturing and Innovation Center

Retrieved on: 
Wednesday, July 19, 2023

PARSIPPANY, N.J., July 19, 2023 /PRNewswire/ -- Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, announced its launch of the JTS Extendible Prosthesis, a novel growing implant designed for pediatric patients with bone cancer, and unveiled its new, state-of-the-art manufacturing and R&D innovation center at its Parsippany, NJ headquarters to support the integration and growth of the technology.

Key Points: 
  • The JTS Extendible Prosthesis is a growing implant with a significant body of clinical evidence for pediatric patients with bone cancer.
  • The addition of the JTS technology expands the company's access and ability to provide solutions for pediatric patients.
  • The new manufacturing facility and innovation center will enable a more agile production environment and provide a world-class experience for our customers.
  • For more information on Onkos Surgical and its products and services, please visit www.onkossurgical.com .

Tetrous Announces First EnFix RC™ Surgical Cases Outside the United States

Retrieved on: 
Thursday, July 13, 2023

LOS ANGELES, July 13, 2023 /PRNewswire/ -- Tetrous Inc., a leading regenerative medicine company today announced that it has completed the first surgical cases in Australia using EnFix RC, a procedure-specific implant for rotator cuff repair that is specifically designed to address Enthesis Failure Syndrome. The procedures were performed successfully by Dr. Kenneth Cutbush, Dr. Ivan Popoff and Dr. Doron Sher. 

Key Points: 
  • Tetrous rapidly expands availability of EnFix RC outside the U.S. with 8 procedures performed by three independent surgeons located in the cities of Brisbane and Sydney, Australia.
  • "It is exciting that Tetrous is dedicated to developing new technology focused on healing the enthesis in rotator cuff surgery.
  • The pre-clinical data is very compelling showing enthesis reformation at 12 weeks," said Dr. Jerome Goldberg, M.B., B.S., F.R.A.C.S., F.A.
  • EnFix RC for rotator cuff repair has performed magnificently and we expect to see widespread adoption in both the U.S. and Australia."

FIRST SURGICAL PROCEDURES IN THE WORLD USING TETROUS ENFIX RC™ FIBER IMPLANT TO ENHANCE ROTATOR CUFF REPAIR PERFORMED AT RUSH OAK BROOK SURGERY CENTER

Retrieved on: 
Tuesday, July 11, 2023

LOS ANGELES, July 11, 2023 /PRNewswire/ -- Tetrous Inc., a leading regenerative medicine company today announced that it has completed the first four surgical cases using EnFix RC, a procedure-specific implant for rotator cuff repair that is specifically designed to address Enthesis Failure Syndrome. Dr. Nikhil Verma, MD. Professor and Director, Division of Sports Medicine, Fellowship Director, Department of Orthopedics, Rush University Medical Center, Team Physician Chicago White Sox and Chicago Bulls, who performed the first four surgeries with the EnFix RC said: "I was thrilled to be the first surgeon to deploy the EnFix RC.  I used one EnFix RC in each case to augment the medial suture anchor fixation. Initially I was impressed with the concept of flipping the script compared to most of the products today for surgical augmentation.  I also was very pleased with how the implant and instrument design was optimized, simplifying the delivery of the product into the interface between the tendon and the bone. The procedure is minimally disruptive to the way rotator cuff surgeries are typically performed. I plan to use the EnFix RC routinely moving forward."

Key Points: 
  • I used one EnFix RC in each case to augment the medial suture anchor fixation.
  • Initially I was impressed with the concept of flipping the script compared to most of the products today for surgical augmentation.
  • In the United States alone, nearly 500,000 rotator cuff repairs are performed annually and 20% to 70% of these repairs fail structurally.
  • The EnFix RC rotator cuff implant is made from proprietary demineralized cortical bone fibers.

A Fascinating Fusion of Facts & Fiction, "Music on the Bones" is for the Rock and Roll Fan in Everybody

Retrieved on: 
Thursday, July 6, 2023

LOS ANGELES, July 6, 2023 /PRNewswire/ -- How did the iconic music of the 1960's, especially rock and roll, make its way from the heart of America to the ears of Russian youth during a time when it was banned in the Soviet Union? 

Key Points: 
  • The surprising answer to this question is among the many gems of little-known information found in the pages of the new book Music on the Bones .
  • An album and a feature film based on the powerful story inspired by true events are also in the works.
  • Music on the Bones follows the plight of Max, a young Russian doctor, who is Jewish and trapped behind the Iron Curtain.
  • He and his friends are striving to work for freedom of expression, and freedom from oppression, against an Orwellian backdrop of constant surveillance and persecution.

Medimaps Group Deep-tech TBS Software Endorsed by International Experts Working Group To Inform Osteoporosis Management Decisions for The Benefit of The Patient

Retrieved on: 
Wednesday, July 5, 2023

The peer-reviewed article provides endorsed guidance to clinicians looking to enhance the assessment and management of osteoporosis with Medimaps Group TBS iNsight™ software for patient benefit.

Key Points: 
  • The peer-reviewed article provides endorsed guidance to clinicians looking to enhance the assessment and management of osteoporosis with Medimaps Group TBS iNsight™ software for patient benefit.
  • Worldwide, osteoporosis causes more than 8.9 million fractures every year, resulting in an osteoporosis fracture every 3 seconds.
  • The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study.
  • Osteoporosis International, 32, pp.251-25
    Harvey, et al., 2015, Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice, Bone , Volume 78 , Pages 216-224